Catalytically active guanylyl cyclase-B requires glycosylation and mutations that inhibit this process cause dwarfism.

about

Catalytically active guanylyl cyclase-B requires glycosylation and mutations that inhibit this process cause dwarfism.

Item

http://www.wikidata.org/entity/Q45914923

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Catalytically active guanylyl ...... t this process cause dwarfism.

@en

Catalytically active guanylyl ...... t this process cause dwarfism.

@nl

type

Item

label

Catalytically active guanylyl ...... t this process cause dwarfism.

@en

Catalytically active guanylyl ...... t this process cause dwarfism.

@nl

prefLabel

Catalytically active guanylyl ...... t this process cause dwarfism.

@en

Catalytically active guanylyl ...... t this process cause dwarfism.

@nl

P1476

Catalytically active guanylyl ...... t this process cause dwarfism.

@en

P2093

Aaron B Edmond

http://www.w3.org/2001/XMLSchema#string

Deborah M Dickey

http://www.w3.org/2001/XMLSchema#string

Lincoln R Potter

http://www.w3.org/2001/XMLSchema#string

Thomas Chaffee

http://www.w3.org/2001/XMLSchema#string

P2860

Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature in patients initially classified as idiopathic short stature

Identification and functional characterization of two novel NPR2 mutations in Japanese patients with short stature

Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux

Defective cellular trafficking of missense NPR-B mutants is the major mechanism underlying acromesomelic dysplasia-type Maroteaux

Intact kinase homology domain of natriuretic peptide receptor-B is essential for skeletal development

Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteaux.

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene.

Guanylyl cyclase structure, function and regulation.

Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Identification and characterization of the major phosphorylation sites of the B-type natriuretic peptide receptor.

P2888

2050-6511-16-s1-a44

P304

A44-A44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2050-6511-16-S1-A44

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P921

glycosylation

P932

4565539

http://www.w3.org/2001/XMLSchema#string